Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just saw AbbVie filed for FDA approval on Rinvoq for treating vitiligo - kind of a big deal if you follow biotech. They've been testing this for non-segmental vitiligo specifically, and apparently the Phase 3 data looked solid with patients showing major skin repigmentation improvements by week 48. The thing about vitiligo is it's been tough to treat, so a new option could actually matter for patients dealing with it. Rinvoq is already approved for stuff like rheumatoid arthritis and Crohn's, so they're basically expanding the drug into dermatology now. If the FDA and EMA greenlight this vitiligo indication, could open up a whole new market for them. Curious to see how long the approval process takes - these things usually move pretty slow. Anyone tracking AbbVie's pipeline?